Joey Wong, Senior Investor Research Analyst, Hong Kong BD, LSN
RESI JPM 2024 is less than a month away. For this highly anticipated conference, LSN’s Investor Research Team has curated a lineup of 7 panels covering a wide range of topics relevant to early-stage investments and innovations.
Some of these panels will highlight specific leading or emerging sectors/ indications, such as Early-Stage Therapeutics, Medical Devices and Mental and Behavioral health, aiming to discuss cutting edge innovations, latest investment trends and the future outlook in these areas. Other panels will focus on different types of investors or strategics partners, such as Big Pharma, Health System Partners, Cross Border Investments and Family Offices, featuring active investors from corresponding groups to shed light on their investment approaches and strategies, recent deals or activities, the roles their play in the ecosystem, and how companies can seek to work with group like theirs, etc.
We are honored to be joined by a diverse group of panelists from around the globe, each bringing unique backgrounds and experiences. Through organizing these panels, our goal is to foster communications, bridge the gap between entrepreneurs and investors/strategic partners and assist founders and CEOs in navigating their fundraising and business development journey in this highly competitive landscape. If you are around for JPM, don’t miss the opportunity to hear from and connect with seasoned investors and executives at these RESI panels!
Here are the speakers for RESI JPM 2024:
 Brent Ahrens General Partner Canaan Partners |
 Jing Bao Partner Shanghai Healthcare Capital |
 Tara Bishop Founder & Managing Director Black Opal Ventures |
 Scarlett Chen Managing Partner Verge Health Tech Fund |
 William Dai Founding Partner ShangBay Capital |
 Jakob Dupont Executive Partner, Private Equity Sofinnova Investments |
 Alex Fair Managing Partner Medstartr Ventures |
 Marissa Fayer U.S. Partner Goddess Gaia Ventures |
 Les Funtleyder Healthcare Portfolio Manager E Squared Capital |
 Viral Gandhi Principal KCK MedTech |
 Lindsay Hoover Managing Partner JLS Fund |
 Jochen Hurlebaus Head of Digital Health Innovation Roche Diagnostics |
 Marc Jones CEO Altoida Inc |
 Ekaterine Kortkhonjia Sr. Director, Early Innovation Partnering Johnson & Johnson Innovation |
 Michael Langer Founder & Managing Partner T.Rx Capital |
 Linda Li Partner, Digital Health Cleveland Clinic Ventures |
 James Mayer Partner, CABHI Ventures Centre for Aging + Brain Health Innovation (CABHI) |
 Jeffrey Moore President MP Healthcare Venture Management (MPH) |
 Miguel Moreno Garcia Director of Research SENS Research Foundation |
 Ahmed Mousa Business Development Executive Tamer Group |
 Priya Oberoi Managing General Partner Goddess Gaia Ventures |
 John Pennett Angel Investor Mid Atlantic Bio Angels |
 Rachel Rea Senior Director, Business Development Stryker |
 Liridon Rrushaj Director, Venture Investments OSF Ventures |
 Dennis Sacha Principal IAG Capital Partners |
 Diana Saraceni Founder, Managing Director Panakes Partners |
 Matias Serebrinsky Co-Founder & General Partner PsyMed Ventures |
 Ashim Subedee Director, Catalyst Office Division of Research Innovation and Ventures (DRIVe) |
 Prasad Sunkara Board of Directors NuFund Venture Group |
 Lauren Tyra Chief Scientific Officer Green Park & Golf Ventures |
 Akili Wallace Director and Deal Lead in Business Development Transactions Amgen |
 Tyler Wanke Investor Wanke Family Office |
 Anita Watkins Managing Director Rex Health Ventures |
 Dana Watt Principal Breakout Ventures |
 Tad Weems Managing Director Agilent Technologies |
 Andrew Wong Global Head of Bayer CoLabs Bayer |
 Shann Yu Associate Director AbbVie Ventures |
Next Phase Newsletter 
Leave a comment